Summary: FDA-approved HIV drugs targeting reverse transcriptase (RT) may reduce Alzheimers risk by blocking similar enzymatic activity in the aging brain. Scientists discovered unexpected RT activity… [+9190 chars]
No comments yet. Be the first to comment!